Seog-Soo Han, Ph.D.
Affiliations: | 2002 | University of Iowa, Iowa City, IA |
Area:
Higher Education, Administration EducationGoogle:
"Seog-Soo Han"Parents
Sign in to add mentor| Stephen DesJardins | grad student | 2002 | University of Iowa | |
| (A study of factors influencing college admission and enrollment at the University of Iowa.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Park B, Han S, Byoun HS, et al. (2020) The Assessment of Geometric Reliability of Conventional Trajectory of Ventriculostomy in a Three Dimensional Virtual Model and Proposal of a New Trajectory. Neurologia Medico-Chirurgica |
| Lee C, Park B, Lee SS, et al. (2019) Efficacy of the Monte Carlo method and dose reduction strategies in paediatric panoramic radiography. Scientific Reports. 9: 9691 |
| Kim MK, Woo SM, Park B, et al. (2018) Prognostic Implications of Multiplex Detection of KRAS Mutations in Cell-Free DNA from Patients with Pancreatic Ductal Adenocarcinoma. Clinical Chemistry |
| Kim KH, Joo J, Park B, et al. (2017) Reduced levels of N'-methyl-2-pyridone-5-carboxamide and lysophosphatidylcholine 16:0 in the serum of patients with intrahepatic cholangiocarcinoma, and the correlation with recurrence-free survival. Oncotarget. 8: 112598-112609 |
| Ahn HS, Han SH, Kim YH, et al. (2017) Adverse fetal outcomes in pregnant rabbits experimentally infected with rabbit hepatitis E virus. Virology. 512: 187-193 |
| Yoon HS, Kim G, Ju YJ, et al. (2017) Distinct pattern of immune tolerance in dendritic cells treated with lipopolysaccharide or lipoteichoic acid. Molecular Immunology. 91: 57-64 |
| Woo SM, Kim MK, Joo J, et al. (2017) Induction Chemotherapy with Gemcitabine and Cisplatin Followed by Simultaneous Integrated Boost-Intensity Modulated Radiotherapy with Concurrent Gemcitabine for Locally Advanced Unresectable Pancreatic Cancer: Results from a Feasibility Study. Cancer Research and Treatment : Official Journal of Korean Cancer Association |
| Liu T, Park B, Hwang T, et al. (2008) Clinical proof-of-concept with JX-594, a novel targeted multi-mechanistic oncolytic poxvirus, in patients with refractory liver tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3573 |